Stocks · News reference
This Parabilis Medicines Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday
Top Wall Street analysts changed outlook on top stocks. See full analyst rating changes & buy/sell recommendations for PBLS stock on Benzinga.
Reference details
Connected markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Jul 6, 2026, 11:11 AM
- Checked
- Jul 6, 2026, 11:15 AM
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related headlines
Morgan Stanley Maintains Overweight on ERock, Raises Price Target to $23
Morgan Stanley analyst Angel Castillo maintains ERock (NYSE:EROC) with a Overweight and raises the price target from $21 to $23.
Read original at benzingaERock Stock Surges Thursday: What's Driving the Action?
Shares of ERock are surging Thursday following the company's second-quarter financial results reported Tuesday after market close.
Read original at benzingaGold Gains 1%; Performance Food Group Shares Fall After Q4 Results
Dow Jones up 0.1%, NASDAQ up 0.47%, S&P 500 up 0.24%. Tech stocks up 1.1%, communication services down 1.3%. Performance Food Group shares down 6% after reporting earnings miss. AII up 17%, EROC up 20%, BOXL up 69%. NCMI down 31%, UAMY down 22%, STRO down 16%. Oil down 0.1%, gold up 1.1%. Eurozone mixed, Asian markets close mixed. CPI rises 3.4% year-over-year in July.
Read original at benzingaForbright Bank To Sell Its Washington, D.C.-Area Legacy Branches And ~$750M In Local Deposits To Trustar Bank For A Deposit Premium Of ~$19M
The Company expects the Transaction to be accretive to 2027 earnings.Shaza Andersen, Chief Executive Officer of Trustar Bank, stated, "We are very pleased to enter into this Agreement with Forbright Bank. I have
Read original at benzingaWells Fargo Maintains Overweight on Forbright, Raises Price Target to $22
Wells Fargo analyst Terry McEvoy maintains Forbright (NASDAQ:FRBT) with a Overweight and raises the price target from $21 to $22.
Read original at benzinga